-
A.
Maraveyas,
J.
Waters,
R.
Roy,
D.
Propper,
D.
Fyfe,
F.
Lofts,
G.
Bozas,
E.
Gardiner,
J.
Sgouros,
K.
Wedgewood
(2010)
OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)
Thrombosis Research, 125
-
Chapter 8:
-
E.
Chisci,
G.
Donato,
S.
Michelagnoli,
M.
Cecchi,
L.
Ercolini,
S.
Saccardi,
C.
Setacci
(2017)
CORRIGENDUM to 2016 VEITHsymposium/ISVS Associate Faculty Global Podium Presentations
Vascular, 25
-
D.
Moher,
A.
Liberati,
J.
Tetzlaff,
D.
Altman
(2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Journal of clinical epidemiology, 62 10
-
A.
Abdelkefi,
T.
Othman,
L.
Kammoun,
M.
Chelli,
N.
Romdhane,
A.
Kriaa,
S.
Ladeb,
L.
Torjman,
A.
Lakhal,
W.
Achour,
A.
Hassen,
M.
Hsaïri,
F.
Ladeb,
A.
Abdeladhim
(2004)
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease
Thrombosis and Haemostasis, 92
-
J.
Higgins,
D.
Altman,
P.
Gøtzsche,
P.
Jüni,
D.
Moher,
A.
Oxman,
J.
Savović,
K.
Schulz,
L.
Weeks,
J.
Sterne
(2011)
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
The BMJ, 343
-
R.
Oates-Whitehead,
A.
D'Angelo,
B.
Mol
(2003)
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
The Cochrane database of systematic reviews, 4
-
J.
Hynson
(2000)
Enoxaparin for the prevention of venous thromboembolism.
The New England journal of medicine, 342 2
-
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
-
V.
Kakkar,
J.
Balibrea,
J.
Martínez-González,
P.
Prandoni
(2010)
Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study
Journal of Thrombosis and Haemostasis, 8
-
(2017)
Endovascular aneurysm sealing system (EVAS) for infected abdominal aortic aneurysm
-
R.
Lecumberri,
G.
Vivanco,
A.
Font,
E.
Billalabeitia,
A.
Gúrpide,
J.
Codina,
D.
Isla,
A.
Galán,
I.
Bover,
M.
Dómine,
V.
Vicente,
R.
Rosell,
E.
Rocha
(2013)
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
Thrombosis research, 132 6
-
F.
Doormaal,
M.
Nisio,
H.
Otten,
D.
Richel,
M.
Prins,
H.
Buller
(2011)
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15
-
M.
Karthaus,
A.
Kretzschmar,
H.
Kröning,
M.
Biakhov,
D.
Irwin,
N.
Marschner,
C.
Slabber,
G.
Fountzilas,
A.
Garin,
N.
Abecasis,
W.
Baronius,
G.
Steger,
T.
Südhoff,
C.
Giorgetti,
P.
Reichardt
(2006)
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology, 17 2
-
S.
Haas,
M.
Freund,
D.
Heigener,
L.
Heilmann,
B.
Kemkes‐Matthes,
G.
Tempelhoff,
N.
Melzer,
A.
Kakkar
(2012)
Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer
Clinical and Applied Thrombosis/Hemostasis, 18
-
M.
Bullano,
V.
Willey,
O.
Hauch,
G.
Wygant,
A.
Spyropoulos,
L.
Hoffman
(2005)
Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
Journal of Managed Care Pharmacy : JMCP, 11
-
D.
Clarke‐Pearson,
R.
Coleman,
I.
Synan,
W.
Hinshaw,
W.
Creasman
(1983)
Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin.
American journal of obstetrics and gynecology, 145 5
-
I.
Ben-Aharon,
S.
Stemmer,
L.
Leibovici,
O.
Shpilberg,
A.
Sulkes,
A.
Gafter-Gvili
(2014)
Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies – systematic review and meta-analysis
Acta Oncologica, 53
-
D.
Heaton,
D.
Han,
A.
Inder
(2002)
Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis
Internal Medicine Journal, 32
-
Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer
-
P.
Boraks,
J.
Seale,
Jane
Price,
Gilda
Bass,
M.
Ethell,
D.
Keeling,
P.
Mahendra,
T.
Baglin,
R.
Marcus
(1998)
Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies
British Journal of Haematology, 101
-
T.
Niers,
M.
Nisio,
C.
Klerk,
H.
Baarslag,
H.
Büller,
B.
Biemond
(2007)
Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study
Journal of Thrombosis and Haemostasis, 5
-
M.
Levine,
C.
Gu,
H.
Liebman,
C.
Escalante,
S.
Solymoss,
D.
Deitchman,
L.
Ramirez,
J.
Julian
(2012)
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
Journal of Thrombosis and Haemostasis, 10
-
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial
-
G.
Agnelli,
G.
Gussoni,
C.
Bianchini,
M.
Verso,
M.
Mandalà,
L.
Cavanna,
S.
Barni,
R.
Labianca,
F.
Buzzi,
G.
Scambia,
R.
Passalacqua,
S.
Ricci,
G.
Gasparini,
V.
Lorusso,
E.
Bonizzoni,
M.
Tonato
(2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
The Lancet. Oncology, 10 10
-
D.
Clarke‐Pearson,
W.
Creasman,
R.
Coleman,
I.
Synan,
W.
Hinshaw
(1984)
Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial.
Gynecologic oncology, 18 2
-
E.
Akl,
G.
Kamath,
V.
Yosuico,
S.
Kim,
M.
Barba,
F.
Sperati,
D.
Cook,
H.
Schünemann
(2008)
Thromboprophylaxis for patients with cancer and central venous catheters
Cancer, 112
-
B.
Tamowicz,
A.
Mikstacki,
T.
Urbanek,
K.
Zawilska
(2019)
Mechanical methods of venous thromboembolism prevention: from guidelines to clinical practice.
Polish archives of internal medicine, 129 5
-
J.
Higgins,
D.
Altman
(2008)
Chapter 8: Assessing risk of bias in included studies
-
Rémi
Gondret,
Lionel
Dominici,
B.
Angelard,
Sylvie
Dubos,
Said
Al‐Rawi,
Y.
Huet,
F.
Clergue,
J.
Saint-Guily
(1995)
Safety of preoperative enoxaparin in head and neck cancer surgery
Head & Neck, 17
-
D.
Cerrato,
C.
Ariano,
F.
Fiacchino
(1978)
Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients.
Journal of neurosurgery, 49 3
-
G.
Guyatt,
A.
Oxman,
G.
Vist,
R.
Kunz,
Y.
Falck-Ytter,
P.
Alonso-Coello,
H.
Schünemann
(2008)
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
BMJ : British Medical Journal, 336
-
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
-
A.
Khorana,
C.
Francis,
N.
Kuderer,
M.
Carrier,
T.
Ortel,
T.
Wun,
D.
Rubens,
S.
Hobbs,
R.
Iyer,
D.
Peterson,
A.
Baran,
K.
Kaproth-Joslin,
G.
Lyman
(2017)
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
Thrombosis research, 151
-
M.
Levine,
J.
Hirsh,
A.
Arnold,
M.
Gent,
V.
Bramwell,
K.
Pritchard,
D.
Stewart,
D.
Warr,
P.
Goodwin,
M.
Samosh,
A.
Falanga
(1994)
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
The Lancet, 343
-
N.
Liew,
Gina
Alemany,
P.
Angchaisuksiri,
S.
Bang,
G.
Choi,
D.
Silva,
J.
Hong,
L.
Lee,
Yong-jun
Li,
G.
Rajamoney,
J.
Suviraj,
T.
Tan,
E.
Tse,
L.
Teo,
J.
Visperas,
R.
Wong,
L.
Lee
(2017)
Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
International angiology : a journal of the International Union of Angiology, 36 1
-
A.
Kakkar,
M.
Levine,
Z.
Kadziola,
N.
Lemoine,
V.
Low,
H.
Patel,
G.
Rustin,
Michael
Thomas,
M.
Quigley,
R.
Williamson
(2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 10
-
G.
Lyman,
A.
Khorana,
N.
Kuderer,
Agnes
Lee,
J.
Arcelus,
E.
Balaban,
J.
Clarke,
C.
Flowers,
C.
Francis,
L.
Gates,
A.
Kakkar,
N.
Key,
M.
Levine,
H.
Liebman,
M.
Tempero,
S.
Wong,
A.
Prestrud,
A.
Falanga
(2013)
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 17
-
J.
Perry,
J.
Julian,
N.
Laperriere,
W.
Geerts,
G.
Agnelli,
L.
Rogers,
M.
Malkin,
R.
Sawaya,
R.
Baker,
A.
Falanga,
S.
Parpia,
T.
Finch,
Mark
Levine
(2010)
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
Journal of Thrombosis and Haemostasis, 8
-
O.
Negm,
S.
Saif,
M.
Gharib,
M.
Yousef,
S.
Abd-Elsalam
(2017)
Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma
European Journal of Gastroenterology & Hepatology, 29
-
A.
Graul,
N.
Latif,
Xiaochen
Zhang,
L.
Dean,
M.
Morgan,
R.
Giuntoli,
R.
Burger,
Sarah
Kim,
E.
Ko
(2016)
Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program
International Journal of Gynecologic Cancer, 27
-
A.
Maraveyas,
A.
Maraveyas,
J.
Waters,
R.
Roy,
D.
Fyfe,
D.
Propper,
F.
Lofts,
J.
Sgouros,
Eric
Gardiner,
K.
Wedgwood,
C.
Ettelaie,
G.
Bozas
(2012)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.
European journal of cancer, 48 9
-
A.
Falanga
(2009)
The Incidence and Risk of Venous Thromboembolism Associated With Cancer and Nonsurgical Cancer Treatment
Cancer Investigation, 27
-
R.
Bick
(2003)
Cancer-associated thrombosis.
The New England journal of medicine, 349 2
-
M.
Verso,
G.
Agnelli,
S.
Bertoglio,
Franco
Somma,
F.
Paoletti,
W.
Ageno,
M.
Bazzan,
P.
Parise,
R.
Quintavalla,
E.
Naglieri,
A.
Santoro,
D.
Imberti,
M.
Sorarù,
S.
Mosca
(2005)
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 18
-
M.
Bern,
J.
Lokich,
Sabina
Wallach,
A.
Bothe,
P.
Benotti,
C.
Arkin,
F.
Greco,
M.
Huberman,
C.
Moore
(1990)
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.
Annals of internal medicine, 112 6
-
(1977)
Prevention in patients with intracranial disease
-
Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines
-
D.
Moher,
A.
Liberati,
J.
Tetzlaff,
D.
Altman
(2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine, 6
-
L.
Ek,
E.
Gezelius,
B.
Bergman,
P.
Bendahl,
H.
Anderson,
J.
Sundberg,
M.
Wallberg,
U.
Falkmer,
S.
Verma,
M.
Belting
(2017)
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
Annals of Oncology, 29
-
G.
Agnelli,
D.
George,
A.
Kakkar,
W.
Fisher,
M.
Lassen,
P.
Mismetti,
P.
Mouret,
U.
Chaudhari,
Francesca
Lawson,
A.
Turpie
(2012)
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
The New England journal of medicine, 366 7
-
J.
Higgins,
S.
Green,
J.
Higgins
(2013)
Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration
-
Prevention in patients with intracranial disease by pneumatic of venous thrombosis with intracranial intermittent compression of the calf
-
M.
Monreal,
A.
Alastrué,
Miquel
Rull,
Xavier
Mira,
Jordi
Muxart,
R.
Rosell,
A.
Abad
(1996)
Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin)
Thrombosis and Haemostasis, 75
-
N.
Brunetti,
Enrico
Gesuete,
L.
gennaro,
M.
Correale,
P.
Caldarola,
A.
Gaglione,
M.
Biase
(2017)
Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study.
International journal of cardiology, 230
-
Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis
-
O.
Annibali,
M.
Napolitano,
Giuseppe
Avvisati,
S.
Siragusa
(2018)
Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.
Critical reviews in oncology/hematology, 124
-
D.
Bergqvist,
G.
Agnelli,
A.
Cohen,
A.
Eldor,
P.
Nilsson,
Anne
Moigne-Amrani,
F.
Dietrich-Neto
(2002)
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
The New England journal of medicine, 346 13
-
J.
Heit,
M.
Silverstein,
M.
Silverstein,
D.
Mohr,
T.
Petterson,
W.
O'fallon,
L.
Melton
(2000)
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
Archives of internal medicine, 160 6
-
A.
Khorana
(2009)
Cancer and thrombosis: implications of published guidelines for clinical practice.
Annals of oncology : official journal of the European Society for Medical Oncology, 20 10
-
U.
Pelzer,
B.
Opitz,
G.
Deutschinoff,
M.
Stauch,
P.
Reitzig,
S.
Hahnfeld,
L.
Müller,
M.
Grunewald,
J.
Stieler,
M.
Sinn,
T.
Denecke,
S.
Bischoff,
H.
Oettle,
B.
Dörken,
H.
Riess
(2015)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 18
-
Henrik
Sørensen,
L.
Mellemkjær,
J.
Olsen,
J.
Baron
(2000)
Prognosis of cancers associated with venous thromboembolism.
The New England journal of medicine, 343 25
-
P.
Mismetti,
S.
Laporte,
J.
Darmon,
A.
Buchmuller,
H.
Décousus
(2001)
Meta‐analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
British Journal of Surgery, 88
-
E.
Akl,
S.
Vasireddi,
Sameer
Gunukula,
M.
Barba,
F.
Sperati,
I.
Terrenato,
P.
Muti,
H.
Schünemann
(2018)
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Review)
-
H.
Schünemann,
A.
Oxman,
G.
Vist,
J.
Deeks,
P.
Glasziou
(2011)
Chapter 12: Interpreting results and drawing conclusions
-
M.
Nisio,
F.
Peinemann,
E.
Porreca,
A.
Rutjes
(2015)
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.
The Cochrane database of systematic reviews, 6
-
Q.
Guo,
Bin
Huang,
Jichun
Zhao,
Yukui
Ma,
D.
Yuan,
Yi
Yang,
Xiaojiong
Du
(2017)
Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis
Annals of Surgery, 265
-
A.
Turpie,
A.
Gallus,
W.
Beattie,
J.
Hirsh
(1977)
Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf
Neurology, 27
-
M.
Mandalà,
A.
Falanga,
F
Roila
clinical practice guidelines Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
-
M.
Einstein,
E.
Pritts,
E.
Hartenbach
(2007)
Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review.
Gynecologic oncology, 105 3
-
D.
Atkins,
D.
Best,
P.
Briss,
M.
Eccles,
Y.
Falck-Ytter,
S.
Flottorp,
G.
Guyatt,
R.
Harbour,
M.
Haugh,
D.
Henry,
S.
Hill,
Roman
Jaeschke,
G.
Leng,
A.
Liberati,
N.
Magrini,
J.
Mason,
P.
Middleton,
J.
Mrukowicz,
Dianne
O'Connell,
A.
Oxman,
B.
Phillips,
H.
Schünemann,
T.
Edejer,
H.
Varonen,
G.
Vist,
John
Williams,
S.
Zaza
(2004)
Grading quality of evidence and strength of recommendations
BMJ : British Medical Journal, 328
-
B.
Fisher,
J.
Costantino,
D.
Wickerham,
R.
Cecchini,
W.
Cronin,
A.
Robidoux,
T.
Bevers,
M.
Kavanah,
J.
Atkins,
R.
Margolese,
C.
Runowicz,
J.
James,
L.
Ford,
N.
Wolmark,
N.
Wolmark
(2005)
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Journal of the National Cancer Institute, 97 22
-
M.
Nisio,
E.
Porreca,
H.
Otten,
A.
Rutjes
(2014)
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
The Cochrane database of systematic reviews, 8
-
A.
Young,
L.
Billingham,
G.
Begum,
D.
Kerr,
A.
Hughes,
D.
Rea,
S.
Shepherd,
A.
Stanley,
A.
Sweeney,
J.
Wilde,
K.
Wheatley
(2009)
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial
The Lancet, 373
-
L.
Elting,
C.
Escalante,
C.
Cooksley,
E.
Avritscher,
D.
Kurtin,
L.
Hamblin,
S.
Khosla,
E.
Rivera
(2004)
Outcomes and cost of deep venous thrombosis among patients with cancer.
Archives of internal medicine, 164 15
-
Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures
-
P.
Shukla,
R.
Siddachari,
Sanjay
Ahire,
S.
Arya,
S.
Ramani,
S.
Barreto,
Sudeep
Gupta,
S.
Shrikhande,
P.
Jagannath,
L.
Desouza
(2008)
Postoperative deep vein thrombosis in patients with colorectal cancer.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 27 2